A phase I/II trial of preoperative chemoradiotherapy with gemcitabine in patients with pancreatic cancer and impaired renal function - A phase I/II trial of preoperative chemoradiotherapy with gemcitabine in patients with pancreatic cancer and impaired renal function

Clinical Study Group of Osaka University0 sites8 target enrollmentMarch 30, 2015

Overview

Refer to paper

Registry

who.int

Start Date

March 30, 2015

End Date

March 30, 2017

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Clinical Study Group of Osaka University

•(1\) Unresectable pancreatic cancer (2\) Dialysis patients (3\)Presence or past history of interstitial pneumonia or pulmonary fibrosis or possible (4\) Active infections (excluding viral hepatitis) (5\) Severe cardiac disorder, renal disorder, liver disorder, ulcer with bleeding, intestinal tract paralysis, uncontrollable diabetes mellitus (6\) Presence of pleural effusion or ascites requiring drainage (7\) Presence of metastasis in central nervous system (8\) Active double cancer except carcinoma in situ or intramucosal cancer (synchronous double cancer or asynchronous double cancer with disease\-free duration to be within 3 years) (9\) Pregnant females or nursing mothers who can not stop lactation. Patients or partners, who don't attempt to doing contraception during the study period. (10\) Severe mental disorder (11\) Severe drug hypersensitivity (12\) As determined by the principal investigator or the sub\-investigator the subject is not adequate to participate in the trial.